Credentials
Dr. Hammad maintains a broad certification footprint spanning neurology, procedural pain care, sleep, metabolic medicine, and regenerative science — aligned with complex subspecialty practice.
Board certification
- American Board of Regenerative Medicine (March 2025)
- American Board of Obesity Medicine (February 2019–2029)
- American Board of Pain Medicine (April 2019–2027)
- American Board of Psychiatry and Neurology (October 2016–2026)
- American Board of Sleep Medicine (October 2011–2021 certification cycle)
- American Board of Clinical Neurophysiology (May 2009–2019)
- American Board of Interventional Pain Physicians (April 2022–2029)
- American Board of Internal Medicine (August 2004–2014)
- United Council for Neurologic Subspecialties — clinical neuromuscular pathology (certification eligible, June 2006)
Fellowships & distinctions
- Fellow of the American Academy of Neurology (FAAN) — February 2014–present
- Fellow of Interventional Pain Practice (FIPP), World Institute of Pain — March 2009–present
- Fellow of the American College of Physicians (FACP) — October 2008–present
- Certified Principal Investigator (CPI), American Clinical Research Association — August 2016–present
Postgraduate training selected
- Emory University — neuromuscular, clinical neurophysiology, nerve/muscle pathology + sleep medicine exposure (2004–2005)
- SUNY Stony Brook — combined neurology & internal medicine residency (1999–2004)
- Interventional Orthopedic Foundation fellowship — orthobiologics under imaging guidance (2017–2018)
- American Academy of Anti-Aging — fellowship in anti-aging, metabolic and functional medicine (2016–2018) plus targeted courses (ISSCA stem cell training, ASIPP regenerative medicine cadaver workshop, Centeno-Schultz orthobiologic injection intensive, and related interventional pain review programs)
Medical licensure (summary)
- Dubai Health Authority — August 2023–March 2027
- Florida — January 2006–January 2026
- Georgia — July 2004–May 2020
- Palestine — September 2014–present